Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Stefano Ciardullo"'
Autor:
Federico Rea, Laura Savaré, Valeria Valsassina, Stefano Ciardullo, Gianluca Perseghin, Giovanni Corrao, Giuseppe Mancia
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background To evaluate the protective effect of oral antidiabetic drugs in a large cohort of elderly patients with type 2 diabetes differing for age, clinical status, and life expectancy, including patients with multiple comorbidities and sh
Externí odkaz:
https://doaj.org/article/8189aca8f12c46749019a19d957dbfa1
Autor:
Stefano Ciardullo, Federico Rea, Rosa Cannistraci, Emanuele Muraca, Silvia Perra, Francesca Zerbini, Andrea Mortara, Gianluca Perseghin
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background Even though hyperglycemia is a well-known cardiovascular risk factor, the absolute risk of cardiovascular events varies to a great extent within each glycemic category. The aim of this study is to evaluate whether N-terminal pro-B
Externí odkaz:
https://doaj.org/article/6beb9a31923247f8b6e7f3298914e190
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 2070-2078 (2022)
Abstract Recently, an expert panel proposed diagnostic criteria for metabolic dysfunction–associated fatty liver disease (MAFLD) in the pediatric population. The aim of this study was to evaluate the prevalence of MAFLD among US adolescents and to
Externí odkaz:
https://doaj.org/article/43ac66a6e6fd4b9587828912e7b90cb2
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundCardiovascular disease (CVD) risk is higher in patients with nonalcoholic fatty liver disease (NAFLD).AimTo evaluate whether this can be attributed to the link between NAFLD and known CVD risk factors or to an independent contribution of li
Externí odkaz:
https://doaj.org/article/53ebf0e48d9f43bc994d4cd684f841cc
Autor:
Stefano Ciardullo, Emanuele Muraca, Silvia Perra, Eleonora Bianconi, Francesca Zerbini, Alice Oltolini, Rosa Cannistraci, Paola Parmeggiani, Giuseppina Manzoni, Guido Lattuada, Gianluca Perseghin
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
ObjectiveNon-alcoholic fatty liver disease (NAFLD) is prevalent in patients with type 2 diabetes. Here, we estimate the proportion of patients with type 2 diabetes that should be referred to hepatologists according to the European Association for the
Externí odkaz:
https://doaj.org/article/a11aa416430b478cbb7c0ddcc4c2bd0b
Publikováno v:
Biomolecules, Vol 12, Iss 1, p 105 (2022)
An association between liver stiffness, a surrogate measure of liver fibrosis, and chronic kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD) has been proposed. However, most studies were small and had low statistical powe
Externí odkaz:
https://doaj.org/article/e57d3bd8931440a58adb1e02974edd7b
Publikováno v:
The Liver in Systemic Disease. :99-109
The central function of the liver in the regulation of the metabolisms of hormones and nutrients makes it an integral part of the endocrine system. In everyday clinical practice, the endocrinologist usually encounters patients with altered liver func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e55b0c42b4c8376da3e3ed95df5e0fd
https://doi.org/10.1002/9781119802181.ch8
https://doi.org/10.1002/9781119802181.ch8
Publikováno v:
The American Journal of Clinical Nutrition. 115:1528-1534
Few population-based studies have investigated the association between body fat distribution and the risk of nonalcoholic fatty liver disease (NAFLD) and significant liver fibrosis.We aimed to evaluate the relations of total body fat and body fat dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9810302b15058333777ced6a597b8133
https://doi.org/10.1093/ajcn/nqac059
https://doi.org/10.1093/ajcn/nqac059
Autor:
Stefano Ciardullo, Emanuele Muraca, Rosa Cannistraci, Silvia Perra, Guido Lattuada, Gianluca Perseghin
Publikováno v:
Diabetes/Metabolism Research and Reviews.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3b11b744a80be2deafe7c7a5c212709
https://doi.org/10.1002/dmrr.3628
https://doi.org/10.1002/dmrr.3628
Autor:
Stefano Ciardullo, Emanuele Muraca, Eleonora Bianconi, Celeste Ronchetti, Rosa Cannistraci, Laura Rossi, Silvia Perra, Francesca Zerbini, Gianluca Perseghin
Introduction Serum neurofilament light chain (sNfL) levels are biomarkers of neuro-axonal injury in multiple neurological diseases. Little is known on their potential role as prognostic markers in people without known neurological conditions. Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f086e443541ca8a0afbb4c54f5d6221e
https://hdl.handle.net/10281/413196
https://hdl.handle.net/10281/413196
